EMCDDA. European Web Survey on Drugs 2021: top level findings, 21 EU countries and Switzerland
EMCDDA. European Web Survey on Drugs 2021: top level findings, 21 EU countries and Switzerland
In summary
Most survey respondents (93 %) reported using cannabis during the previous 12 months, 35 % used MDMA/ecstasy, 35 % cocaine and 28 % amphetamine.
The most commonly reported motivations for cannabis use were relaxation, getting high and aiding sleep.
Home was reported as the most common setting for drug use during the period.
The impact of the COVID-19 pandemic and national measures was reported to be greatest on the use of cannabis (increased consumption) and ecstasy/MDMA (decreased consumption). (EMCDDA, Lissabon, 15.12.2021)
https://www.emcdda.europa.eu/publications/data-fact-sheets/european-web-survey-drugs-2021-top-level-findings-eu-21-switzerland_en